Introduction
An essential component of the hepatitis C virus (HCV) lifecycle is the formation of 'lipoviral particles' (LVP) (1) . HCV is co-assembled with the hepatocyte's machinery for export of very-low density lipoproteins (VLDL) (2) . LVP contain not only HCV viral proteins and RNA, but also have physical properties of lipoproteins, being of lowbuoyant density, large size and containing apolipoprotein's B (apoB), apoE and apoA1 (3) . The lipoprotein association increases infectivity of LVPs (4, 5) and decreases susceptibility to antibody mediated neutralisation (6) . We therefore
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hypothesised that formation of LVP is likely to be important in the natural history of early acute HCV infection in determining the probability of spontaneous clearance or persistent infection.
The natural history of acute HCV infection has not been fully defined, but spontaneous clearance occurs in ~25% of those exposed to the virus (7, 8) . Factors related to innate immunity (9) and induction of interferon stimulated genes may be important for early spontaneous clearance (10, 11) . Other factors that have been independently associated with spontaneous clearance include sex, interferon lambda-3 (IFNL3) genotype, interferon-gamma-inducible protein-10, HCV genotype, HIV infection and HBV infection (8, 11, 12) .
LVP have previously been measured in patients with chronic HCV infection in fasting plasma using iodixanol density gradient ultracentrifugation (13, 14) . This method defined a low-density fraction (d <1.07 g/mL), in which all the apoB containing lipoproteins are captured and HCV RNA detected within this fraction was considered to represent apoB associated LVP (14) . HCV RNA in the higher density fraction d>1.07 g/mL that did not contain apoB, were considered 'non-LVPs'. In chronic HCV genotype 1 infection, LVP and LVP ratios were associated with insulin resistance, triglycerides (14) , apoE concentrations and sustained virological response to pegylated interferon and ribavirin therapy (15) . Different metabolic correlations were identified when comparing LVP in HCV genotype 1 to genotype 3 (16). However, variability of density distribution in the post prandial state limits application of this method to non-fasting samples (17) . In order to investigate LVP in non-fasting
samples from a unique cohort of recent HCV infection, a modified LVP assay measuring sized large HCV particles >100nM after ex vivo addition of lipid emulsion (maxi-LVP) was used. It was hypothesised that concentrations of LVP will be higher in early acute HCV infection compared to later duration of infection and that lower LVP levels would independently predict spontaneous HCV clearance. Hence, we evaluated whether i) maxi-LVP is increased in early acute HCV infection (<26 weeks) compared to later (>26 weeks) duration of infection; and ii) the concentrations of maxi-LVP predict spontaneous clearance during recent (acute and early chronic) HCV infection.
Patients and Methods

Study Population and Design
The role of LVPs during recent HCV infection was investigated using stored plasma and data from two studies of recent HCV infection. The methods of both studies have been previously described in detail (18, 19) . The Australian Trial in Acute Hepatitis C (ATAHC) was a prospective study of the natural history and treatment of recent HCV (18) . The Hepatitis C Incidence and Transmission Study in prison (HITSp) is an ongoing study of prison inmates at-risk of acute HCV in correctional centres (19). Stored plasma samples were used to measure maxi-LVP in both ATAHC and HITS-p acute HCV cohorts.
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Laboratory testing
Sample selection
All participants with sufficient available EDTA or acid citrate dextrose (ACD) plasma samples that were HCV RNA positive at the time of acute HCV detection were identified. The laboratory analysis was conducted blinded to the outcomes. In addition, 30 participants from the ATAHC study with high volumes of available EDTA
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or ACD plasma samples (>1 mL) were randomly selected for duplicate testing to calculate the coefficient of variation (CV) for the maxi-LVP methods described below.
Maxi-LVP assay
The maxi-LVP assay was performed by incubating 50 µL of EDTA or ACD plasma with an equal volume of diluted lipid emulsion, (27. 
HCV RNA quantitation
HCV RNA from the retentate (maxi-LVP) and filtrate (non-LVP) were reverse transcribed using AMV Reverse Transcriptase (Promega) and sequence specific primer NCR3 as previously described (23) . cDNA was quantitated using a two-step
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Taq Man Real time PCR as previously described using primers NCR-3 and NCR-5 and dual labelled probe SN1 to the 5' UTR of the HCV genome (23).
Maxi-LVP was defined as the HCV RNA concentration (IU/mL) in the retentate of the filter after incubation with dilute intralipid. HCV RNA was also measured from the filtrate (non-LVP) and the maxi-LVP ratio calculated as retentate / (retentate + filtrate).
Paired stored EDTA plasma in 53 HCV genotype 1 patients were tested using the two LVP assays; i) iodixanol density gradient ultracentrifugation defined LVP as HCV-RNA detected at density <1.07 g/ml (2), ii) Maxi-LVP assay defined LVP as HCV-RNA retained by the 0.1 µM size filter, after incubation with a lipid emulsion.
Pearson's correlation was used to determine the agreement between the two LVP assays (figure 1).
Study outcome
The association of maxi-LVP and non-LVP levels at the first detection of HCV infection with spontaneous HCV clearance was investigated. 
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Statistical analyses
The co-efficient of variation (CV) of maxi-LVP was determined by calculating the standard deviation/mean of the maxi-LVP assay in the ATAHC cohort of 30 randomly selected non-fasting samples run in duplicate. Nonparametric statistical tests were used for analyses, given that maxi-LVP and non-LVP levels (IU/mL) and log10 transformation of maxi-LVP and non-LVP levels (log IU/mL) were not normally distributed. Median maxi-LVP levels, non-LVP levels and maxi-LVP ratio were compared between spontaneous clearance and persistent infection groups using the Wilcoxon-Mann-Whitney test. The proportion of individuals with detectable and undetectable maxi-LVP was compared between spontaneous clearance and persistent infection groups using Chi Square test. Similarly, distribution of maxi-LVP levels, non-LVP levels and maxi-LVP ratio were compared between individuals with estimated duration of infection <26 weeks at the time of HCV detection (early acute HCV infection) and those with an estimated duration of infection >26 weeks at the time of HCV detection.
The association of low maxi-LVP levels and non-LVP levels with spontaneous clearance was assessed using logistic regression. Low maxi-LVP levels and non-LVP levels were defined as equal or lower than median (i.e. ≤827 IU/mL as low maxi-LVP levels and ≤1854 IU/mL as low non-LVP levels). In the adjusted models, the association of low maxi-LVP levels and low non-LVP levels with spontaneous clearance was adjusted for potential confounders including interferon-lambda rs8099917 genotype, HCV RNA levels, and estimated duration of infection. Potential confounders in the adjusted models included variables associated with spontaneous
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clearance in this study (P<0.200). All analyses were performed using Stata v12.0 (College Station, TX, United States).
Results
Participant characteristics
The baseline characteristics of the study cohorts are shown in Table 1 . Among 206 participants in ATAHC and HITS-p, 180 individuals had detectable HCV RNA at initial HCV diagnosis and are included in this analysis (69% male, 18% HIV infected, median total HCV RNA: 4.87 log 10 IU/mL).
Assay development and validation
The validity of the maxi-LVP assay in comparison to iodixanol density gradient ultracentrifugation method was assessed by paired analysis using the two assays from the same stored samples. There was strong correlation between LVP (HCV RNA log10 IU/ml) as measured by iodixanol density gradient vs maxi-LVP methods HCV RNA compared to iodixanol density gradients by -0.97 log10 IU/ml for LVP and -1.15 log10 IU/mL for non-LVP, which was not clinically significant for analysis in this study.
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Maxi-LVP sensitivity and co-efficient of variation
Maxi
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This article is protected by copyright. All rights reserved. (Table 2 ). In contrast, non-LVP was not independently associated with spontaneous HCV clearance after adjusting for IFNL3 rs8099917 genotype, estimated duration of infection and HCV RNA level (Table 3 )
Discussion:
This is the first study to report LVP in the natural history of recent HCV and 
Accepted Article
High concentrations of LVP indicate that HCV has established efficient viral assembly within the liver by co-opting the secretory machinery of VLDL export from hepatocytes (1). The association of HCV with lipoproteins in vivo is dynamic and variable. Quantities of very low density LVP have previously been observed to increase after a high fat meal, and are rapidly cleared (17) . Post prandially, HCV in plasma associates with both liver derived VLDL containing apoB100, and intestinally derived chylomicrons containing apoB48 (17, 24) . In the fasting state, only a minority of HCV RNA (27-37%) were detectable in a very low density fraction (d<1.025 g/L), but following ex vivo addition of post prandial plasma from a healthy volunteer, the amount of HCV RNA in the very low density fraction increased (53-78%) (17) . The significance of this observation is that measurement of LVP by density or size in randomly selected non-fasting samples will be subject to variation dependent on the 
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